TL;DR
By integrating neurobiology with pharmacognosy, this review provides a framework for developing evidence-based functional foods and adjunctive therapies for depression.
An in-depth review of medicinal plants with anti-neuroinflammatory properties, focusing on their bioactive compounds, mode of action, and clinical applications in neurological disorders is given.
Major depressive disorder (MDD) remains a leading cause of disability, with a substantial proportion of patients failing to achieve adequate remission following conventional monoaminergic antidepressant treatment. The present narrative review examines evidence primarily published between 2015 and 2025 concerning natura...
Anxiety, depression, and cognitive dysfunction are closely interconnected neuropsychiatric disorders that share common pathological mechanisms, including hypothalamic–pituitary–adrenal (HPA) axis dysregulation, neurotransmitter imbalance, oxidative stress, neuroinflammation, and impaired neuroplasticity. Although conve...
ABSTRACT Chronic psychological stress is now widely recognised as a precipitating and perpetuating factor in a spectrum of neuropsychiatric conditions, including generalised anxiety disorder, major depressive disorder, post-traumatic stress disorder (PTSD), and stress-related cognitive decline. Dysregulation of the hyp...
Neuroinflammation is a multifaceted process in which specific biomolecules (such as pro-inflammatory cytokines and signaling proteins) act as primary mediators of neuropsychiatric disorders, including depression. Despite growing evidence, the precise interconnected cascades within these neuroinflammatory signaling path...
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.
